Peter Virsik serves as Executive at ESSA Pharma Inc., where they oversee executive responsibilities. Since joining the company, Peter Virsik has executed 13 insider transactions totaling $815.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 9, 2024 involved selling 694 shares valued at $4.2K.
Peter Virsik currently holds 8,470 shares of ESSA Pharma Inc. (EPIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Virsik has been a net seller of EPIX stock. They have purchased $0 and sold $815.1K worth of shares.
Peter Virsik's most recent insider trade was on Sep 9, 2024, when they sold 694 shares at $6.00 per share.
Get notified when new Form 4 filings are submitted
| $6.03 |
| Planned |
| May 6, 2024 | EPIX | $4.8K | Sale | 694 | $6.95 | Planned |
| Apr 5, 2024 | EPIX | $5.5K | Sale | 694 | $7.94 | Planned |
| Mar 5, 2024 | EPIX | $6.2K | Sale | 694 | $8.98 | Planned |
| Feb 6, 2024 | EPIX | $748.9K | Sale | 72,782 | $10.29 | Planned |
| Feb 6, 2024 | EPIX | $235.1K | Option Exercise | 72,782 | $3.23 | Planned |
| Feb 5, 2024 | EPIX | $6.4K | Sale | 694 | $9.25 | Planned |
| Feb 5, 2024 | EPIX | $1.6K | Option Exercise | 500 | $3.23 | Planned |
| Feb 5, 2024 | EPIX | $5.0K | Sale | 500 | $10.04 | Planned |
| Jan 16, 2024 | EPIX | $17.2K | Sale | 1,718 | $10.01 | Planned |
| Jan 16, 2024 | EPIX | $5.5K | Option Exercise | 1,718 | $3.23 | Planned |
| Jan 5, 2024 | EPIX | $4.3K | Sale | 699 | $6.11 | Planned |